• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两项关于帕罗西汀和多塞平治疗老年重度抑郁症患者的联合多中心双盲研究。

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.

作者信息

Dunner D L, Cohn J B, Walshe T, Cohn C K, Feighner J P, Fieve R R, Halikas J P, Hartford J T, Hearst E D, Settle E C

机构信息

University of Washington, Seattle 98105.

出版信息

J Clin Psychiatry. 1992 Feb;53 Suppl:57-60.

PMID:1531827
Abstract

Depressive illness among the elderly is an important public health concern. However, treatment of the elderly may be complicated by age-related changes in physiology, general medical status, and susceptibility to side effects. There is therefore a need for improved treatment modalities for depressed elderly patients. Paroxetine is an antidepressant that acts through selective inhibition of serotonin reuptake. It lacks the anticholinergic and cardiovascular side effects of most first- and second-generation antidepressants. The authors present the combined data from two similarly designed comparisons of paroxetine and doxepin in outpatients over 60 years of age with major depression. The results show that paroxetine was an effective as doxepin in alleviating depression as measured on the Hamilton Rating Scale for Depression (HAM-D) total score, the Montgomery and Asberg Depression Rating Scale (MADRS), and the Hopkins Symptom Checklist (SCL) depression factor score. Paroxetine was significantly superior to doxepin on the Clinical Global Impressions (CGI) scale for severity of illness, the HAM-D retardation factor, and the HAM-D depressed mood item. Doxepin produced significantly more anticholinergic effects, sedation, and confusion. Paroxetine was associated with more reports of nausea and headache. These results suggest that paroxetine may be a valuable tool for the treatment of major depression in the elderly.

摘要

老年期抑郁症是一个重要的公共卫生问题。然而,老年人的治疗可能会因生理、一般医疗状况以及副作用易感性方面与年龄相关的变化而变得复杂。因此,需要改进针对老年抑郁症患者的治疗方式。帕罗西汀是一种通过选择性抑制5-羟色胺再摄取而起作用的抗抑郁药。它没有大多数第一代和第二代抗抑郁药的抗胆碱能及心血管副作用。作者呈现了两项针对60岁以上患有重度抑郁症的门诊患者进行的帕罗西汀与多塞平的类似设计比较的综合数据。结果显示,在汉密尔顿抑郁量表(HAM-D)总分、蒙哥马利-艾斯伯格抑郁量表(MADRS)以及霍普金斯症状清单(SCL)抑郁因子评分方面,帕罗西汀在缓解抑郁方面与多塞平效果相当。在临床总体印象量表(CGI)的病情严重程度、HAM-D迟缓因子以及HAM-D抑郁情绪项目上,帕罗西汀显著优于多塞平。多塞平产生的抗胆碱能效应、镇静作用及意识模糊更为明显。帕罗西汀引发恶心和头痛的报告更多。这些结果表明,帕罗西汀可能是治疗老年重度抑郁症的一种有价值的药物。

相似文献

1
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.两项关于帕罗西汀和多塞平治疗老年重度抑郁症患者的联合多中心双盲研究。
J Clin Psychiatry. 1992 Feb;53 Suppl:57-60.
2
The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.在一项针对门诊抑郁症患者的双盲试验中,帕罗西汀与安慰剂相比的安全性和有效性。
J Clin Psychiatry. 1992 Feb;53 Suppl:33-5.
3
A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.一项针对门诊抑郁症患者的为期6周的帕罗西汀、丙咪嗪和安慰剂双盲试验。
J Clin Psychiatry. 1992 Feb;53 Suppl:40-3.
4
Paroxetine in the treatment of depression: a comparison with imipramine and placebo.帕罗西汀治疗抑郁症:与丙咪嗪和安慰剂的比较。
J Clin Psychiatry. 1992 Feb;53 Suppl:44-7.
5
A placebo- and imipramine-controlled study of paroxetine.一项关于帕罗西汀的安慰剂和丙咪嗪对照研究。
Psychopharmacol Bull. 1990;26(2):185-9.
6
Paroxetine versus placebo: a double-blind comparison in depressed patients.帕罗西汀与安慰剂对比:抑郁症患者的双盲对照研究
J Clin Psychiatry. 1992 Dec;53(12):434-8.
7
A double-blind, placebo-controlled study of paroxetine in depressed outpatients.一项针对抑郁症门诊患者的帕罗西汀双盲、安慰剂对照研究。
J Clin Psychiatry. 1992 Feb;53 Suppl:27-9.
8
The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.帕罗西汀与安慰剂相比治疗门诊重度抑郁症患者的疗效与安全性。
J Clin Psychiatry. 1992 Feb;53 Suppl:30-2.
9
A double-blind comparison of paroxetine, imipramine, and placebo in major depression.帕罗西汀、丙咪嗪与安慰剂治疗重度抑郁症的双盲对照研究
J Clin Psychiatry. 1992 Feb;53 Suppl:48-51.
10
Paroxetine in major depression: a double-blind trial with imipramine and placebo.帕罗西汀治疗重度抑郁症:与丙咪嗪和安慰剂的双盲试验。
J Clin Psychiatry. 1992 Feb;53 Suppl:52-6.

引用本文的文献

1
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review.帕金森病中抑郁症的药物与非药物治疗:最新综述。
Medicina (Kaunas). 2023 Aug 12;59(8):1454. doi: 10.3390/medicina59081454.
2
Paroxetine versus other anti-depressive agents for depression.帕罗西汀与其他抗抑郁药治疗抑郁症的比较
Cochrane Database Syst Rev. 2014 Apr 3;2014(4):CD006531. doi: 10.1002/14651858.CD006531.pub2.
3
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.一项抗抑郁药治疗帕金森病的随机、双盲、安慰剂对照试验。
Neurology. 2012 Apr 17;78(16):1229-36. doi: 10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11.
4
Treatment of depression in late life.老年期抑郁症的治疗
Dialogues Clin Neurosci. 1999 Sep;1(2):113-24. doi: 10.31887/DCNS.1999.1.2/lschneider.
5
Use of antidepressants in late-life depression.抗抑郁药在老年抑郁症中的应用。
Drugs Aging. 2008;25(10):841-53. doi: 10.2165/00002512-200825100-00003.
6
Antidepressants for depressed elderly.用于老年抑郁症患者的抗抑郁药
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD003491. doi: 10.1002/14651858.CD003491.pub2.
7
Spotlight on paroxetine in psychiatric disorders in adults.聚焦成人精神疾病中的帕罗西汀。
CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006.
8
Paroxetine: an update of its use in psychiatric disorders in adults.帕罗西汀:成人精神疾病应用的最新进展
Drugs. 2002;62(4):655-703. doi: 10.2165/00003495-200262040-00010.
9
Paroxetine: a review.帕罗西汀:综述
CNS Drug Rev. 2001 Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x.
10
Selective serotonin reuptake inhibitors for late-life depression: a comparative review.用于老年期抑郁症的选择性5-羟色胺再摄取抑制剂:一项比较性综述。
Drugs Aging. 2001;18(5):355-68. doi: 10.2165/00002512-200118050-00006.